Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03971344 · ClinicalTrials.gov registry record

Impact of Serious Pediatric Illness on Parent and Sibling Health

A clinical trial, sponsored by Children's Hospital of Philadelphia.

Completed
Registry status
161,000
Enrollment target

NCT03971344: Completed study, sponsored by Children's Hospital of Philadelphia.

NCT03971344 is a clinical trial that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 161,000 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03971344 has completed, sponsored by Children's Hospital of Philadelphia.

COMPLETED
Registry status
161,000 participants
Enrollment target

Study Summary

To estimate the impact of having a child with serious illness (SI) on the health and healthcare of other members of the child's family.

Primary Outcome

Outcome will be assessed based on diagnoses in de-identified claims data

Trial Details

FieldValue
Enrollment Target 161,000 participants
Start Date 2020-01-30
Est. Completion 2020-07-31
Children's Hospital of Philadelphia

431 total trials

What the finished NCT03971344 record still lists

NCT03971344 is an observational study that tracks outcomes without assigning an intervention. Its 161,000 participants enrollment target places it among the larger protocols in the corpus.

The record links to 0 conditions, and to 0 interventions.

NCT03971344 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03971344 about?

NCT03971344 is a clinical study titled "Impact of Serious Pediatric Illness on Parent and Sibling Health". To estimate the impact of having a child with serious illness (SI) on the health and healthcare of other members of the child's family.

What is the current status of trial NCT03971344?

This trial is currently completed. The enrollment target is 161,000 participants. The study started on 2020-01-30. Estimated completion is 2020-07-31.

Who is sponsoring clinical trial NCT03971344?

This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06917339 · 156,000 participants

    Retrospective Analyses of TrakStar Database

  • NCT06232551 · 152,000 participants · NA

    Alerting Providers at Patient Hospital Discharge to Consider Prescribing Rivaroxaban to Reduce Venous Thromboembolism

  • NCT06090578 · 180,000 participants · NA

    TabCAT Brain Health Assessment in Primary Care

  • NCT05994482 · 130,000 participants

    Surveillance Colonoscopy in Older Adults: The SurvOlderAdults Study

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03971344, the US trial registry maintained by the National Library of Medicine. NCT03971344 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.